• 3205 Citations
  • 32 h-Index
1987 …2020
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Andrea Pace is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 27 Similar Profiles
Brain Neoplasms Medicine & Life Sciences
Consensus Medicine & Life Sciences
Pain Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Glioma Medicine & Life Sciences
Psychology Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Epilepsy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1987 2020

The influence of patient sex on clinical approaches to malignant glioma

Matteoni, S., Abbruzzese, C., Villani, V., Malorni, W., Pace, A., Matarrese, P. & Paggi, M. G., Jan 1 2020, In : Cancer Letters. 468, p. 41-47 7 p.

Research output: Contribution to journalShort survey

Open Access

A multicenter real-world study of bevacizumab in heavily pretreated malignant gliomas: Clinical benefit is a plausible end point?

Villani, V., Fabi, A., Tanzilli, A., Pasqualetti, F., Lombardi, G., Vidiri, A., Gonnelli, A., Molinari, A., Cantarella, M., Bellu, L., Terrenato, I., Carosi, M., Maschio, M., Telera, S. M., Carapella, C. M., Cognetti, F., Paiar, F., Zagonel, V. & Pace, A., May 2019, In : Future Oncology. 15, 15, p. 1717-1727 11 p.

Research output: Contribution to journalArticle

Comorbidities in elderly patients with glioblastoma: A field-practice study

Villani, V., Tanzilli, A., Telera, S. M., Terrenato, I., Vidiri, A., Fabi, A., Zucchella, C., Carapella, C. M., Marucci, L., Casini, B., Carosi, M., Oppido, P. M. & Pace, A., Mar 2019, In : Future Oncology. 15, 8, p. 841-850 10 p.

Research output: Contribution to journalArticle

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

Italian Association of Neuro-Oncology, May 6 2019, In : Journal of Neuro-Oncology. 142, 3, p. 455-62 8 p.

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Disease-Free Survival
IDN 5109
Recurrence

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

the Italian Association of Neuro-Oncology, Silvani, A., De Simone, I., Fregoni, V., Biagioli, E., Marchioni, E., Caroli, M., Salmaggi, A., Pace, A., Torri, V., Gaviani, P., Quaquarini, E., Simonetti, G., Rulli, E. & D’Incalci, M., Jan 1 2019, In : Journal of Neuro-Oncology. 142, 3, p. 455-462

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Disease-Free Survival
IDN 5109
Recurrence